Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting-Reference-Cited by-同舟云学术

Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting

Published:2023-10 Issue:10 Volume:7 Page:869-878
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Yoneda Keisuke,Takeuchi Masaru,Yasukawa Tsutomu^ORCID,Terasaki Hiroto,Yamamoto Yuki^ORCID,Jujo Tatsuya,Wakuta Makiko,Matsubara Hisashi,Mitamura Yoshinori^ORCID,Kato Aki^ORCID,Kondo Mineo,Kimura Kazuhiro,Takagi Hitoshi,Gomi Fumi^ORCID,Sakamoto Taiji

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Ophthalmology

Reference41 articles.

1. Mechanisms of age-related macular degeneration;Ambati;Neuron,2012

2. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis;Flaxman;Lancet Glob Health,2017

3. Safety and efficacy of anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration: a report by the American Academy of Ophthalmology;Bakri;Ophthalmology,2019

4. Retinal angiomatous proliferation in age-related macular degeneration. 2001;Yannuzzi;Retina,2012

5. Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of ‘expanded spectra’ - a review;Dansingani;Clin Exp Ophthalmol,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration and its Subtypes from the Societal and Patient Perspectives in Japan;Ophthalmology and Therapy;2024-08-10

2. Effects of Combination Therapy with Intravitreal Ranibizumab and Tissue Plasminogen Activator for Neovascular Age-Related Macular Degeneration;Journal of Clinical Medicine;2024-04-21